Patient 002: A Novel
From the author of In the Shadow of Memory, a memoir of living with brain damage, comes a novel about the battleground of human medical research - told from the patient's point of view.
At 41, Sam Kiehl was a successful political consultant, a long-distance runner and rock climber, the single father of a grown son, and lover of a popular newspaper columnist. Then he contracted a virus that targeted his brain and left him totally disabled. With few treatment options available and his health continuing to worsen, Sam seizes upon the chance to offer himself as a subject in the clinical field trial of a new drug, Zomalovir. He becomes "Patient 002" and joins a group of patients from all walks of life who are similarly afflicted and desperate. What happens to Sam, to the young woman named Tracy Marsh with whom he is partnered, and to the others in his group, provides a sometimes shocking, sometimes humorous, always dramatic picture of human medical research, a world seldom seen. As the research subjects respond - or fail to respond - to their experimental treatment, as participating doctors and nurses observe, and as Physicians for Ethical Research, the pharmaceutical company that developed the drug and operates the study, deals with harsh truths about the costs and risks of conducting research, Patient 002 becomes a tale of choices made and consequences faced at the center of the illness experience.
Patient 002 is also a love story, as Sam discovers passion and romance in an unexpected place. It's also a novel of friendships forged in extreme circumstances and of the human capacity for survival in the face of overwhelming obstacles.
What people are saying - Write a review
Review: Patient 002User Review - Tahni - Goodreads
First I want to say that I didn't actually finish this book, and I feel kind of bad about that. It wasn't a bad book - not at all. The writing was good, the characters were very well developed, and ... Read full review
Review: Patient 002User Review - Sue - Goodreads
Didn't like it at all. Only read 1/2. Was too slow and boring. Sam has a virus and he's in a drug trial. Read full review